课题基金 / 基金详情

Establishment and validation of corrected SUVmax correlated with prognosis following stereotactic body radiotherapy for non-small cell lung cancer

Establishment and validation of corrected SUVmax correlated with prognosis following stereotactic body radiotherapy for non-small cell lung cancer
非小细胞肺癌立体定向放疗后校正SUVmax与预后相关的建立和验证
批准号:
23591850
负责人:
TAKEDA Atsuya
金额:
$3.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

TAKEDA Atsuya的其他基金

相似基金

相关文献

中文摘要
翻译
SUVmax是FDG-PET积累的一个指标,有望成为多种癌症的预后因素。但它是一个相对指标,受肿瘤大小、呼吸运动、肿瘤背景、仪器等因素的影响。我们做了一个运动幻体的实验,尝试用肿瘤大小和呼吸运动来修正SUVmax。其次,对非小细胞癌患者立体定向放疗的治疗结果数据,探讨校正后的SUVmax的可用性。结果表明,实际SUVmax和校正SUVmax与局部控制和无病控制具有良好的相关性。然而,修正后的SUVmax并没有显示出与这些结果有更大的相关性。
英文摘要
SUVmax is an index of accumulation in FDG-PET, and is expected to be a prognostic factor of various cancer. However, it is a relative index and is affected by tumor size, respiratory movement, tumor background, instrument and so on. We made an experiment using moving phantom and tried to correct SUVmax modified with tumor size and respiratory movement. Next, availability of the corrected SUVmax was investigated on the treatment results data of stereotactic body radiotherapy for patients with non-small cell cancer.As results, actual SUVmax and corrected SUVmax were correlated well with local control and disease-free control. However, corrected SUVmax was not shown to be more correlated with those outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of Clarithromycin on prevention of radiation pneumonitis
  • 批准号:
    16K10403
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2016
  • 负责人:
    TAKEDA Atsuya
  • 依托单位:
海外基金